The American Heart Association has released a new scientific statement, “Caffeine and Cardiovascular Disease,” published in its flagship journal Circulation, providing updated guidance on caffeine consumption. The statement concludes that for most adults, consuming up to 400 mg of caffeine per day—equivalent to about 5 cups of caffeinated coffee—is safe and may be linked to a lower risk of cardiovascular conditions such as heart failure, heart disease, and stroke. However, higher doses, particularly from energy drinks and shots, can increase the risk of high blood pressure and arrhythmias.
“Caffeine consumed in coffee is a key part of daily life for millions of people, and in our review of the most recent research, for most adults, intake of up to 400 mg of caffeine/day… is safe and does not increase cardiovascular risk,” said Dr. Gregory M. Marcus, chair of the statement writing group. “However, high doses of caffeine, such as those found in energy drinks including energy shots, may have harmful effects on the heart and should be avoided.”
The statement reviewed studies on caffeine’s effects on blood pressure, cholesterol, Type 2 diabetes, coronary heart disease, stroke, heart failure, atrial fibrillation, and other conditions. Key findings include that black caffeinated coffee without added sugars or cream was associated with lower risks of Type 2 diabetes, heart disease, stroke, and some arrhythmias. However, adding sugar, syrups, milk, or cream likely reduces health benefits. High caffeine intake from energy drinks, which contain 3–4 times more caffeine per ounce than coffee, was linked to cardiovascular harm.
Not all sources of caffeine are equal. Coffee contains bioactive compounds with antioxidant and anti-inflammatory properties that may contribute to benefits. Unfiltered coffee (e.g., espresso, French press) contains cafestol, which can raise LDL (“bad”) cholesterol, while paper-filtered or instant coffee does not. Tea has also been associated with reduced risks of atrial fibrillation and stroke.
The statement emphasizes that individual responses to caffeine vary due to genetics, age, medications, and health status. Short-term effects may include temporary increases in blood pressure, heart rate, and alertness, but tolerance can develop. “There is no ‘one-size-fits-all’ strategy for safe caffeine consumption,” Marcus noted, advising people to pay attention to their body’s response and consult healthcare teams.
The AHA’s 2026 Dietary Guidance did not include caffeine-specific recommendations due to insufficient data, and the statement calls for more randomized controlled trials, especially on energy drinks. The writing group included experts from the AHA’s Council on Lifestyle and Cardiometabolic Health, the Council on Clinical Cardiology, and the Stroke Council. The full statement is available online at Circulation.
For business and technology leaders, this statement underscores the importance of understanding how workplace caffeine consumption—from coffee to energy drinks—affects employee health and productivity. Companies may consider promoting healthier options and providing education, especially as energy drinks are popular among younger workers. The findings also highlight the need for clear labeling of caffeine content in products, an area where technology can play a role in transparency.
